Skip to main content
Spexis AG logo

Spexis AG — Investor Relations & Filings

Ticker · SPEX ISIN · CH0106213793 LEI · 391200S8HJE1I96FIG04 SW Manufacturing
Open in API
Filings indexed 194 across all filing types
Latest filing 2023-05-30 Earnings Release
Country CH Switzerland
Listing SW SPEX

About Spexis AG

https://www.polyphor.com/

Spexis AG is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutics for rare diseases and oncology. The company leverages its expertise in macrocycle technology to create novel drug candidates designed to address high unmet medical needs. Its pipeline is advanced through a strategy that includes in-house discovery, development, in-licensing, and the acquisition of promising molecules. The primary therapeutic areas of interest include rare diseases and cancer, with an additional focus on antimicrobial resistance.

Recent filings

Filing Released Lang Actions
Spexis informiert über die aktuelle Geschäftsentwicklung und gibt Finanzergebnis für das Geschäftsjahr 2022 bekannt
Earnings Release Classification · 100% confidence The document is titled "Ad hoc-Mitteilung gemäss Art. 53 KR" (Ad hoc announcement according to Art. 53 KR) and its primary purpose is to announce the financial results for the fiscal year 2022 ("Finanzergebnis für das Geschäftsjahr 2022 bekannt"). It contains key financial highlights, a summary table of the P&L and Balance Sheet for 2022 vs 2021, and updates on clinical pipeline progress. This structure strongly indicates an Earnings Release (ER), which is the initial announcement of periodical financial results. Although it covers the full year, the format is that of a press release announcing the results, not the comprehensive 10-K filing itself. Since it is a release of annual financial results, ER is the most appropriate code, as AR (Audit Report) is usually reserved for standalone audit opinions, and 10-K is the formal SEC filing which this Swiss ad-hoc announcement is not. FY 2022
2023-05-30 German
Spexis has received temporary approval of an extension until 31 of May 2023 for the disclosure obligation in connection with the publication and the filing of the annual report 2022.
Report Publication Announcement Classification · 99% confidence The document is an 'Ad hoc announcement' dated April 28, 2023, stating that the company received temporary approval for an extension until May 31, 2023, for the disclosure obligation related to the 'publication and the filing of the annual report 2022'. Although it contains unaudited key figures for 2022, the primary purpose of this short announcement is to communicate the regulatory extension regarding the Annual Report (10-K equivalent) filing deadline, not to publish the full report itself. According to Rule 2 (The 'MENU VS MEAL' Rule), a document announcing the publication or filing of a report, especially when it's a regulatory update about the filing process, should be classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since this specifically concerns the publication schedule of a major report (Annual Report), RPA is the most appropriate classification, as it announces the publication status/delay. It is not the 10-K itself, nor is it a general Earnings Release (ER) which focuses on results highlights.
2023-04-28 English
Spexis has received temporary approval of an extension until 31 of May 2023 for the disclosure obligation in connection with the publication and the filing of the annual report 2022.
Report Publication Announcement Classification · 99% confidence The document is an 'Ad hoc announcement pursuant to Art. 53 LR' from Spexis AG. The core content is the announcement that the company received an extension until May 31, 2023, for the disclosure obligation related to the publication and filing of its 'annual report 2022'. Crucially, it states that the unaudited key figures for the 2022 annual results are included below. This document is not the full Annual Report (10-K) itself, nor is it a standard Earnings Release (ER) which typically contains the full results. Instead, it is an announcement *about* the timing of the annual report publication and provides preliminary data as required by the regulatory decision. Since it is an announcement regarding the publication of a major report (Annual Report) and includes key figures/updates, it fits best under the category of a Report Publication Announcement (RPA), as it serves to inform the market about the status and timing of the official filing, often mandated by regulatory bodies (like SIX Exchange Regulation AG in this case). It is not a general Regulatory Filing (RNS) because it specifically concerns the publication schedule of the Annual Report and includes financial highlights.
2023-04-28 English
Spexis erhält vorläufige Genehmigung für eine Ausnahme bzw. Befreiung von der Offenlegungspflicht im Zusammenhang mit der Veröffentlichung des Geschäftsberichts 2022
Report Publication Announcement Classification · 99% confidence The document is titled 'Ad hoc-Mitteilung gemäss Art. 53 KR' and is dated April 28, 2023. The core content is an announcement regarding the granting of an extension for the publication deadline of the '2022 annual report' until May 31, 2023, by SIX Exchange Regulation AG. It also includes unaudited key figures for the 2022 annual results. Since this document is an official, time-sensitive announcement (Ad-hoc) concerning the timing and status of a major regulatory filing (the Annual Report), and it provides preliminary financial data as required by the regulator for the announcement, it is best classified as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) due to the inclusion of key figures. However, the primary purpose is communicating the regulatory decision regarding the Annual Report deadline, not releasing the full results themselves. Given the context of Swiss regulatory announcements (Ad hoc-Mitteilung) that often serve as immediate disclosures, and the fact that it is not the full 10-K or IR, RNS is the most appropriate general regulatory category for this specific type of procedural announcement, although it touches upon annual results. Since the document is short and announces the status of a report rather than being the report itself, it avoids 10-K or IR. It is not a standard ER which usually contains the full results summary. Therefore, RNS (Regulatory Filings) is the best fit for this specific regulatory communication.
2023-04-28 German
Spexis announces closing of capital commitment of USD 4.5 million from SPRIM Global Investments (SGI) to enable initiation of ColiFin Phase 3 study
Capital/Financing Update Classification · 99% confidence The document is an 'Ad-hoc' announcement dated April 18, 2023, detailing the closing of a capital commitment of USD 4.5 million from SPRIM Global Investments (SGI). The content focuses on financing activities ('Funding to enable immediate initiation of the COPILOT study', 'Commitment structured as a mix of secured debt and subordinated debt mandatorily converting into equity'). This directly aligns with the definition of 'Capital/Financing Update' (Code: CAP). Although it mentions management transitions, the primary focus and headline concern the capital raise necessary for clinical trials.
2023-04-18 English
Spexis announces closing of capital commitment of USD 4.5 million from SPRIM Global Investments (SGI) to enable initiation of ColiFin® Phase 3 study
Share Issue/Capital Change Classification · 99% confidence The document is titled 'Ad hoc announcement pursuant to Art. 53 LR' and explicitly announces the 'closing of capital commitment of USD 4.5 million' structured as debt and equity conversion. This content directly relates to fundraising and changes in the capital structure. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it is an 'Ad hoc announcement' (which might suggest RNS), the specific subject matter (financing/capital commitment) makes CAP the most precise classification. The length (6516 chars) is substantial enough that it is the primary document content, not just a brief announcement of a report.
2023-04-18 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.